PATENT CLAIM ANALYSIS

Application Number: 15765933
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["530", "315000"]

Abstract:
The present invention relates to new solid phase peptide methods for synthesizing analogues that exhibit oxytocin antagonist activity, specifically Barusiban and its intermediates. Specifically, the present invention relates to a solid phase process for preparing a compound having the formula c[AA 1 -AA 6 ]-AA 7 -ol, wherein AA 1  is propionic acid, AA 2  is preferably D-Trp, AA 3  is Ile, AA 4  is preferably AlloIle, AA 5  is Asn, AA 6  is hCy, and AA 7  is preferably N-Me-Orn-ol, or a pharmaceutically acceptable salt or solvate thereof.

Claim (Index 2):
The solid phase process according to  claim 1 , wherein the resin is 2-CTC.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 91.0
- Lexical Diversity: 1.65079
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11929494', '11457743', '13959931', '15145901', '11938776']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6693773272532725
- 35 USC 102 Novelty (BERT): 0.5305043892029806
- Combined Prediction Score: 0.6554900334482433
- Mean Citation Score: 268.686994
- Max Citation Score: 288.8439
- Similarity Product: 148.60888443635704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test